XML 59 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Shareholders' Equity (Tables)
9 Months Ended
Sep. 30, 2012
Shareholders' Equity [Abstract]  
Fair values of stock option grants estimated with weighted average assumptions
                                 
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2012     2011     2012     2011  

Dividend yield

    0     0     0     0

Expected life

    4 years       4 years       4 years       4 years  

Expected volatility

    73     73     73     74

Risk-free interest rate

    0.5     0.8     0.6     1.2
Impact on the results of operations of recording stock-based compensation expense
                                 
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2012     2011     2012     2011  

Cost of revenue — service

  $ 34     $ 184     $ 242     $ 560  

Selling, general and administrative

    (267     346       355       1,000  

Research and development

    26       48       89       125  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total stock-based compensation expense

  $ (207   $ 578     $ 686     $ 1,685  
   

 

 

   

 

 

   

 

 

   

 

 

 

Per diluted share

  $ (0.02   $ 0.05     $ 0.06     $ 0.14  
   

 

 

   

 

 

   

 

 

   

 

 

 
Summary of stock option activity under the plans
                                 

Stock Options

  Number of
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
(in years)
    Aggregate
Intrinsic
Value
 

Balance at January 1, 2012

    1,939,475     $ 4.49                  

Granted at fair value

    164,875       3.44                  

Exercised

    (82,424     2.43                  

Forfeited

    (309,932     6.85                  

Expired

    (85,627     7.06                  
   

 

 

                         

Balance at September 30, 2012

    1,626,367     $ 3.90       4.12     $ 485,000  
   

 

 

   

 

 

   

 

 

   

 

 

 

Vested and expected to vest at September 30, 2012

    1,581,671     $ 3.90       3.99     $ 482,000  
   

 

 

   

 

 

   

 

 

   

 

 

 

Exercisable at September 30, 2012

    1,319,717     $ 3.90       3.06     $ 448,000  
   

 

 

   

 

 

   

 

 

   

 

 

 
Summary of certain information about stock options
                                 
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2012     2011     2012     2011  

Weighted-average grant-date fair value of option grants for the period

  $ —       $ 3.67     $ 2.23     $ 4.52  
   

 

 

   

 

 

   

 

 

   

 

 

 

Options in-the-money at period end

    616,350       1,040,047       616,350       1,040,047  
   

 

 

   

 

 

   

 

 

   

 

 

 

Aggregate intrinsic value of options exercised

  $ 34,000     $ 119,000     $ 67,000     $ 871,000  
   

 

 

   

 

 

   

 

 

   

 

 

 
Summary of Restricted Stock Award activity
                 
    Number of
Shares
    Weighted
Average
Grant-Date
Fair Value Per
Share
 

Unvested at December 31, 2011

    27,000     $ 6.49  

Granted

    —         —    

Vested

    (27,000     6.49  

Forfeited

    —         —    
   

 

 

   

 

 

 

Unvested at September 30, 2012

    0     $ 0.00  
   

 

 

   

 

 

 

Expected to vest after September 30, 2012

    0     $ 0.00  
   

 

 

   

 

 

 
Summary of Restricted Stock Unit activity
                 
    Number of
Shares
    Weighted Average
Grant Date Fair
Value
 

Unvested at December 31, 2011

    241,248     $ 6.20  

Granted

    177,592       3.49  

Vested

    (95,103     4.97  

Forfeited

    (26,019     6.28  
   

 

 

   

 

 

 

Unvested at September 30, 2012

    297,718     $ 4.97  
   

 

 

   

 

 

 

Expected to vest after September 30, 2012

    268,879     $ 4.88  
   

 

 

   

 

 

 
Summary of shares of common stock reserved for future issuance under the Plans
         
    September 30,
2012
 

Stock options outstanding

    1,626,367  

Restricted stock units outstanding

    297,718  

Stock options available for future grant

    1,071,447  
   

 

 

 

Common stock reserved for future issuance

    2,995,532